Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.

Amylin infusion reduces food intake and slows body weight gain in rodents. In obese male rats, amylin (but not pair feeding) caused a preferential reduction of fat mass with protein preservation despite equal body weight loss in amylin-treated (fed ad libitum) and pair-fed rats. In the present study, the effect of prior or concurrent food restriction on the ability of amylin to cause weight loss was evaluated. Retired female breeder rats were maintained on a high-fat diet (40% fat) for 9 wk. Prior to drug treatment, rats were either fed ad libitum or food restricted for 10 days to lose 5% of their starting body weight. They were then subdivided into treatment groups that received either vehicle or amylin (100 microgxkg(-1)xday(-1) via subcutaneous minipump) and placed under either a restricted or ad libitum feeding schedule (for a total of 8 treatment arms). Amylin 1) significantly reduced body weight compared with vehicle under all treatment conditions, except in always restricted animals, 2) significantly decreased percent body fat in all groups, and 3) preserved lean mass in all groups. These results indicate that amylin's anorexigenic and fat-specific weight loss properties can be extended to a variety of nutritive states in female rats.

[1]  L. Aronne,et al.  Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity , 2008, Diabetes Care.

[2]  P. Wielinga,et al.  Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin , 2007, Physiology & Behavior.

[3]  J. Leahy,et al.  Peroxisome Proliferator–Activated Receptor-γ Regulates Expression of PDX-1 and NKX6.1 in INS-1 Cells , 2007, Diabetes.

[4]  R. Gill,et al.  Induction of Indoleamine 2,3-Dioxygenase by Interferon-γ in Human Islets , 2007, Diabetes.

[5]  C. Anderson,et al.  Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. , 2006, Endocrinology.

[6]  E. Melanson,et al.  Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[7]  S. Heymsfield,et al.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. , 2005, The Journal of clinical investigation.

[8]  R. Seeley,et al.  The effect of the melanocortin agonist, MT-II, on the defended level of body adiposity. , 2005, Endocrinology.

[9]  S. Doran,et al.  Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes , 2005, Diabetologia.

[10]  O G Kolterman,et al.  Amylin replacement with pramlintide as an adjunct to insulin therapy improves long‐term glycaemic and weight control in Type 1 diabetes mellitus: a 1‐year, randomized controlled trial , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[11]  C. Weyer,et al.  Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients. , 2004, Obesity research.

[12]  C. Weyer,et al.  Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. , 2003, Diabetes care.

[13]  E. Simon,et al.  Salmon calcitonin – a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents , 2002, The Journal of physiology.

[14]  E. Scharrer,et al.  The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats , 2001, International Journal of Obesity.

[15]  B. Levin,et al.  Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[16]  S. Woods,et al.  Amylin: a novel action in the brain to reduce body weight. , 2000, Endocrinology.

[17]  S. Woods,et al.  Amylin and insulin interact to reduce food intake in rats. , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  R. Considine,et al.  Leptin and the regulation of body weight. , 1997, The international journal of biochemistry & cell biology.

[19]  A. Young Amylinʼs physiology and its role in diabetes , 1997 .

[20]  N. Geary,et al.  The increased satiating potency of CCK-8 by estradiol is not mediated by upregulation of NTS CCK receptors , 1996, Brain Research.

[21]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[22]  P. C. Butera,et al.  Modulation of the satiety effect of cholecystokinin by estradiol , 1993, Physiology & Behavior.

[23]  A. Young,et al.  No measurable effect of amylin on lipolysis in either white or brown isolated adipocytes from rats , 1993 .

[24]  Christine Jones,et al.  Printed in Great Britain , 1970 .